Northern Trust Corp Catabasis Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
N/A
-84,357 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
N/A
-173,385 Reduced 67.27%
84,357 $178,000
Q1 2021

May 12, 2021
SELL
N/A
-33,108 Reduced 11.38%
257,742 $745,000
Q4 2020

Feb 11, 2021
SELL
N/A
-2,572 Reduced 0.88%
290,850 $623,000
Q3 2020

Nov 16, 2020
BUY
N/A
138,835 Added 89.81%
293,422 $1.82 Million
Q2 2020

Aug 14, 2020
BUY
N/A
77,203 Added 99.77%
154,587 $994,000
Q1 2020

May 14, 2020
BUY
N/A
5,138 Added 7.11%
77,384 $321,000
Q4 2019

Feb 14, 2020
BUY
N/A
14,087 Added 24.22%
72,246 $427,000
Q3 2019

Nov 13, 2019
BUY
N/A
7,966 Added 15.87%
58,159 $314,000
Q2 2019

Aug 13, 2019
BUY
N/A
21,458 Added 74.68%
50,193 $405,000
Q1 2019

May 13, 2019
BUY
N/A
11,987 Added 71.57%
28,735 $228,000
Q4 2018

Feb 12, 2019
BUY
N/A
16,748 New
16,748 $73,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email